Gamelin Erick 4
4 · Acrivon Therapeutics, Inc. · Filed Nov 16, 2023
Insider Transaction Report
Form 4
Gamelin Erick
Chief Development Officer
Transactions
- Tax Payment
Common Stock
2023-11-14$5.08/sh−1,395$7,087→ 18,635 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.